FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2520308051> ?p ?o ?g. }

• W2520308051 abstract "Abstract Objective: Determination of the factors associated with the intensive care unit (ICU) prognosis and mortality has important role in the clinical follow-up of the patients. Definition of novel biomarkers, beside older biomarkers available for evaluation of the outcome of these patients has been proposed. Platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme that inactivates the platelet-activating factor. A reduction in the level of the PAF-AH has been demonstrated during systemic inflammation and multiple organ failure. This research aims to determine whether measurement of PAF-AH enzyme activity in ICUs can be used as a prognostic indicator like conventional biomarkers. Methods: Eighty five adult patients have been included. Following data have been recorded: preliminary C-reactive protein (CRP), lactate, albumin and PAF-AH values, APACHE II scores and discharge forms from ICU. Patients were divided in two groups with respect to APACHE II values: Group 1 (1-19) and Group 2 (≥20). Results: Observed mortality was 51.2%. In the APACHE II Group 2 patients, the values of CRP (p=0.001) and lactate (p=0.040) were significanty high, and the values of PAF-AH (p=0.008) and albumin (p=0.001) were significantly low. A statistically significant difference was found between PAF-AH values of exitus and alive patients (p=0.001). According to ROC analysis, the sensitivity and specificity of predicting mortality was 70.5% and 70.7% for CRP, 63.6% and 70.7% for lactate, 90.2% and 61.4% for albumin and 63.6% and 70% PAF-AH, respectively. Conclusion: Our study demonstrated that, in predicting the ICU mortality risk, sensitivity of the PAF-AH is similar to the sensitivity of the lactate, and specificity of the PAF-AH is better than that of the albumin. According to our results, PAF-AH can be included in the novel biomarkers." @default.
• W2520308051 created "2016-09-23" @default.
• W2520308051 creator A5021268202 @default.
• W2520308051 creator A5040107489 @default.
• W2520308051 creator A5055483323 @default.
• W2520308051 creator A5073463152 @default.
• W2520308051 creator A5076475158 @default.
• W2520308051 date "2016-01-01" @default.
• W2520308051 modified "2023-10-01" @default.
• W2520308051 title "Evaluation of predictive effect of PAF-AH on the prognosis of intensive care unit patients / Yoğun bakım hastalarında PAF-AH’ın prognoz üzerindeki prediktif etkisinin değerlendirilmesi" @default.
• W2520308051 cites W1490888454 @default.
• W2520308051 cites W1965669732 @default.
• W2520308051 cites W1971866770 @default.
• W2520308051 cites W1974391150 @default.
• W2520308051 cites W1992663437 @default.
• W2520308051 cites W2035116744 @default.
• W2520308051 cites W2039115564 @default.
• W2520308051 cites W2046785185 @default.
• W2520308051 cites W2048462883 @default.
• W2520308051 cites W2051392147 @default.
• W2520308051 cites W2059586410 @default.
• W2520308051 cites W2070794781 @default.
• W2520308051 cites W2072964256 @default.
• W2520308051 cites W2088844134 @default.
• W2520308051 cites W2089959473 @default.
• W2520308051 cites W2093529460 @default.
• W2520308051 cites W2095067395 @default.
• W2520308051 cites W2113932715 @default.
• W2520308051 cites W2143532457 @default.
• W2520308051 cites W2329867620 @default.
• W2520308051 cites W4293242440 @default.
• W2520308051 doi "https://doi.org/10.1515/tjb-2016-0016" @default.
• W2520308051 hasPublicationYear "2016" @default.
• W2520308051 type Work @default.
• W2520308051 sameAs 2520308051 @default.
• W2520308051 citedByCount "2" @default.
• W2520308051 countsByYear W25203080512022 @default.
• W2520308051 countsByYear W25203080512023 @default.
• W2520308051 crossrefType "journal-article" @default.
• W2520308051 hasAuthorship W2520308051A5021268202 @default.
• W2520308051 hasAuthorship W2520308051A5040107489 @default.
• W2520308051 hasAuthorship W2520308051A5055483323 @default.
• W2520308051 hasAuthorship W2520308051A5073463152 @default.
• W2520308051 hasAuthorship W2520308051A5076475158 @default.
• W2520308051 hasBestOaLocation W25203080511 @default.
• W2520308051 hasConcept C126322002 @default.
• W2520308051 hasConcept C177713679 @default.
• W2520308051 hasConcept C2776125364 @default.
• W2520308051 hasConcept C2776376669 @default.
• W2520308051 hasConcept C2779020240 @default.
• W2520308051 hasConcept C2780347030 @default.
• W2520308051 hasConcept C2987404301 @default.
• W2520308051 hasConcept C71924100 @default.
• W2520308051 hasConcept C90924648 @default.
• W2520308051 hasConceptScore W2520308051C126322002 @default.
• W2520308051 hasConceptScore W2520308051C177713679 @default.
• W2520308051 hasConceptScore W2520308051C2776125364 @default.
• W2520308051 hasConceptScore W2520308051C2776376669 @default.
• W2520308051 hasConceptScore W2520308051C2779020240 @default.
• W2520308051 hasConceptScore W2520308051C2780347030 @default.
• W2520308051 hasConceptScore W2520308051C2987404301 @default.
• W2520308051 hasConceptScore W2520308051C71924100 @default.
• W2520308051 hasConceptScore W2520308051C90924648 @default.
• W2520308051 hasIssue "2" @default.
• W2520308051 hasLocation W25203080511 @default.
• W2520308051 hasOpenAccess W2520308051 @default.
• W2520308051 hasPrimaryLocation W25203080511 @default.
• W2520308051 hasRelatedWork W1792058206 @default.
• W2520308051 hasRelatedWork W1980692720 @default.
• W2520308051 hasRelatedWork W2057630253 @default.
• W2520308051 hasRelatedWork W2070132559 @default.
• W2520308051 hasRelatedWork W2395699535 @default.
• W2520308051 hasRelatedWork W2403653627 @default.
• W2520308051 hasRelatedWork W2404937035 @default.
• W2520308051 hasRelatedWork W2770627120 @default.
• W2520308051 hasRelatedWork W2971728166 @default.
• W2520308051 hasRelatedWork W3205123072 @default.
• W2520308051 hasVolume "41" @default.
• W2520308051 isParatext "false" @default.
• W2520308051 isRetracted "false" @default.
• W2520308051 magId "2520308051" @default.
• W2520308051 workType "article" @default.